Similarly, restoration of radio-sensitivity was observed when antisense oligonucleotides (AS-ODNs) were used to inhibit GLUT1 activity in laryngeal carcinoma cells (Chan et al., 2004; Yan et al., 2013). This evidence concerns the gene SLC2A1 and laryngeal carcinoma.